Dados B3Stocks › CSAN3 PT

Consumo não-Cíclico

CSAN3 — COSAN S.A.

CNPJ 50.746.577/0001-15 · listed classes: CSAN3 · CVM code 19836

-2.3P/E
4.3P/B
17.9EV/EBITDA
20.1%FCF yield
-120.0%ROE 2025
-0.2%ROIC 2025
P/E, P/B and EV/EBITDA priced at the session of 2026-03-09 (R$ 5.74), the first one after the 2025 filing became public on 2026-03-09 — point-in-time, not the 31 December price. pl_negativo

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator201120122013201420152016201720182019202020212022202320242025
ROE 11.9%!33.4%3.3%!7.5%11.6%14.3%17.1%23.7%8.0%47.9%6.6%5.3%-59.2%-120.0%
ROIC 6.9%!23.1%8.1%!10.8%!15.3%13.4%12.4%15.2%9.3%20.7%!10.3%!13.0%2.4%!-0.2%!
ROA 4.1%!12.9%2.4%!3.4%4.8%5.4%6.6%8.1%2.6%9.5%2.4%3.6%-5.8%-7.4%
Gross margin 16.1%10.9%28.8%29.9%39.2%34.2%25.3%29.3%27.3%25.5%22.6%27.7%31.2%32.6%
EBIT margin 7.4%17.6%18.2%24.0%37.0%37.4%26.7%26.5%18.0%34.8%19.8%33.0%8.0%-0.5%
Net margin 4.3%11.0%7.9%11.5%18.4%19.7%18.5%18.3%6.7%25.5%7.1%12.4%-18.6%-25.2%
Revenue growth (1y) 33.4%32.9%3.7%-9.7%1.7%34.3%31.8%-0.4%84.4%59.5%0.4%11.4%-8.0%
Revenue growth (5y CAGR) -16.0%-20.0%10.9%10.7%10.1%27.0%39.0%30.8%26.5%24.5%
Net debt/EBITDA 2.85x0.63x2.84x2.56x1.51x1.88x2.18x1.76x3.57x3.01x3.97x2.90x7.60x11.76x
Current ratio 1.41x2.27x1.34x1.54x1.96x1.56x1.90x1.84x1.78x2.11x1.62x1.77x1.72x2.58x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarterrevenueprofitnet marginP/E TTMP/Bfiled on
2024T19,842.1263.52.7%14.31.252024-05-28
2024T210,694.0-969.5-9.1%9.61.272024-08-14
2024T311,646.31,026.88.8%9.51.072024-11-13
2025T1!9,662.6-1,935.4-20.0%-1.31.822025-05-15
2025T2!10,477.7-568.1-5.4%-0.91.402025-08-14
2025T3!10,664.2-834.4-7.8%-0.91.952025-11-14
2026T1!9,028.8-1,345.0-14.9%-1.95.222026-05-14
2026T2!10,775.9186.81.7%-1.52.632026-08-14

Full series, every quarter: GET /empresas/CSAN3/trimestres

Dividends per year

yearper sharepayments
2024R$ 0.45151
2023R$ 0.42861
2022R$ 0.42811
2021R$ 1.40522
2020R$ 1.49781
2019R$ 0.99981
2018R$ 1.10861
2017R$ 0.93171

Piotroski F-Score 4/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal yearaccountfirst filingrestated
2013DRE 3.016,878.26,128.8
2012DRE 3.0124,096.923,390.5
2012DRE 3.02-21,465.0-20,887.6
2021DRE 3.02-18,568.0-19,123.2
2021DRE 3.036,339.15,783.9
2013DRE 3.02-4,878.2-4,430.8
2022DRE 3.0139,737.439,322.8
2013DRE 3.032,000.01,698.0

This company appears in

Other companies in Consumer Defensive

26 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/CSAN3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 4,137 sessions, 2010-01-04 → 2026-09-04 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:36 UTC. If this does not match /saude, you are reading a cached copy.